FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154463931> ?p ?o ?g. }

• W2154463931 endingPage "427" @default.
• W2154463931 startingPage "420" @default.
• W2154463931 abstract "Although randomized controlled trials support the use of intensive medical and invasive therapies for non-ST segment elevation acute coronary syndromes (NSTE-ACS), major bleeding is a serious treatment complication. We sought to determine the temporal trend of in-hospital major bleeding among patients with NSTE-ACS, in relation to the evolving management pattern.We identified 14 111 NSTE-ACS patients enrolled in 4 successive, prospective, multicenter registries (ACS I, 1999-2001; ACS II, 2002-2003; GRACE, 2004-2007; and CANRACE, 2008) in Canada between 1999 and 2008. We collected data on patient characteristics, use of cardiac medications and procedures on standardized case report forms. In all registries, major bleeding was defined a priori as life threatening or fatal bleeding, bleeding requiring transfusion of ≥2 U of packed red cells, or resulting in an absolute decrease in hemoglobin of >30g/L.A total of 14 111 patients had a final diagnosis of NSTE-ACS and were included in this study (3294 in the ACS-I registry, 1956 in the ACS-II registry, 7543 in GRACE, and 1318 in CANRACE). Over time, there was a substantial increase in the use of dual anti-platelet (aspirin and thienopyridine) therapy (P for trend <.001), and in rates of in-hospital cardiac catheterization and percutaneous coronary intervention (both Ps for trend <.001). Overall, major bleeding was relatively infrequent (1.7%). There was no significant increase in the unadjusted rates of major bleeding over time (P for trend = .19). In multivariable analysis adjusting for GRACE risk score and intensive treatment, enrolment period was not an independent predictor of bleeding (P for trend = .98). There was no interaction between the enrolment period and the use of intensive medical and invasive management.Despite more widespread use of dual anti-platelet therapies and invasive cardiac procedures in the management of NSTE-ACS, the rate of major bleeding remains relatively low and has not increased significantly over time. Our findings suggest that physicians selectively target treatment for their patients, and these evidence-based therapies can be safely administered to ACS patients in clinical practice." @default.
• W2154463931 created "2016-06-24" @default.
• W2154463931 creator A5001797210 @default.
• W2154463931 creator A5005779148 @default.
• W2154463931 creator A5016160940 @default.
• W2154463931 creator A5034363730 @default.
• W2154463931 creator A5039466154 @default.
• W2154463931 creator A5044702594 @default.
• W2154463931 creator A5047187243 @default.
• W2154463931 creator A5056476744 @default.
• W2154463931 creator A5064977823 @default.
• W2154463931 creator A5070716494 @default.
• W2154463931 creator A5080397161 @default.
• W2154463931 date "2010-09-01" @default.
• W2154463931 modified "2023-09-24" @default.
• W2154463931 title "Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes" @default.
• W2154463931 cites W1531021320 @default.
• W2154463931 cites W1539505594 @default.
• W2154463931 cites W1553345686 @default.
• W2154463931 cites W1573872903 @default.
• W2154463931 cites W1596397105 @default.
• W2154463931 cites W1973543600 @default.
• W2154463931 cites W1982781765 @default.
• W2154463931 cites W1983126671 @default.
• W2154463931 cites W1987303952 @default.
• W2154463931 cites W1990538732 @default.
• W2154463931 cites W1997993375 @default.
• W2154463931 cites W2004512399 @default.
• W2154463931 cites W2012144065 @default.
• W2154463931 cites W2045713748 @default.
• W2154463931 cites W2048471256 @default.
• W2154463931 cites W2050683601 @default.
• W2154463931 cites W2059215195 @default.
• W2154463931 cites W2069255298 @default.
• W2154463931 cites W2069921149 @default.
• W2154463931 cites W2087914195 @default.
• W2154463931 cites W2094802314 @default.
• W2154463931 cites W2095901832 @default.
• W2154463931 cites W2097678778 @default.
• W2154463931 cites W2099409915 @default.
• W2154463931 cites W2102447786 @default.
• W2154463931 cites W2104517604 @default.
• W2154463931 cites W2114198397 @default.
• W2154463931 cites W2121251309 @default.
• W2154463931 cites W2124153207 @default.
• W2154463931 cites W2132856094 @default.
• W2154463931 cites W2134124835 @default.
• W2154463931 cites W2149599987 @default.
• W2154463931 cites W2154783291 @default.
• W2154463931 cites W2158157517 @default.
• W2154463931 cites W2163815180 @default.
• W2154463931 cites W2167460281 @default.
• W2154463931 cites W2170181314 @default.
• W2154463931 cites W2171941310 @default.
• W2154463931 cites W2315322366 @default.
• W2154463931 cites W2325460018 @default.
• W2154463931 cites W2611749980 @default.
• W2154463931 cites W635046673 @default.
• W2154463931 cites W94521306 @default.
• W2154463931 doi "https://doi.org/10.1016/j.ahj.2010.05.036" @default.
• W2154463931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20826248" @default.
• W2154463931 hasPublicationYear "2010" @default.
• W2154463931 type Work @default.
• W2154463931 sameAs 2154463931 @default.
• W2154463931 citedByCount "25" @default.
• W2154463931 countsByYear W21544639312012 @default.
• W2154463931 countsByYear W21544639312013 @default.
• W2154463931 countsByYear W21544639312014 @default.
• W2154463931 countsByYear W21544639312015 @default.
• W2154463931 countsByYear W21544639312016 @default.
• W2154463931 countsByYear W21544639312018 @default.
• W2154463931 countsByYear W21544639312019 @default.
• W2154463931 countsByYear W21544639312020 @default.
• W2154463931 countsByYear W21544639312021 @default.
• W2154463931 crossrefType "journal-article" @default.
• W2154463931 hasAuthorship W2154463931A5001797210 @default.
• W2154463931 hasAuthorship W2154463931A5005779148 @default.
• W2154463931 hasAuthorship W2154463931A5016160940 @default.
• W2154463931 hasAuthorship W2154463931A5034363730 @default.
• W2154463931 hasAuthorship W2154463931A5039466154 @default.
• W2154463931 hasAuthorship W2154463931A5044702594 @default.
• W2154463931 hasAuthorship W2154463931A5047187243 @default.
• W2154463931 hasAuthorship W2154463931A5056476744 @default.
• W2154463931 hasAuthorship W2154463931A5064977823 @default.
• W2154463931 hasAuthorship W2154463931A5070716494 @default.
• W2154463931 hasAuthorship W2154463931A5080397161 @default.
• W2154463931 hasConcept C126322002 @default.
• W2154463931 hasConcept C164705383 @default.
• W2154463931 hasConcept C194828623 @default.
• W2154463931 hasConcept C2776291336 @default.
• W2154463931 hasConcept C2777628954 @default.
• W2154463931 hasConcept C2777698277 @default.
• W2154463931 hasConcept C2777849778 @default.
• W2154463931 hasConcept C2779837110 @default.
• W2154463931 hasConcept C2780400711 @default.
• W2154463931 hasConcept C3017811039 @default.
• W2154463931 hasConcept C500558357 @default.
• W2154463931 hasConcept C71924100 @default.

• next